Nature:Nature封面!付向东团队在体将胶质细胞转化为神经元

2020-06-25 MedSci原创 MedSci原创

来自不同脑区的星形胶质细胞可以转化为不同的神经元亚型。

帕金森病的特征是大脑黑质部的多巴胺神经元的丧失。与其他主要的神经退行性疾病相似,至今为止,帕金森病没有任何改变疾病的治疗方法。

已有的大多数治疗策略的目的是防止神经元的损失或保护脆弱的神经元电路,此外,还有一个潜在的替代方案是取代失去的神经元,重建中断的脑回路。

最近,付向东团队报告了一个高效的一步转换法,通过耗尽RNA结合蛋白PTB(也称为PTBP1),其可以将分离得到的小鼠和人类星形胶质细胞转分化为有功能的神经元。

将这种方法应用于小鼠大脑,研究人员证明了星形胶质细胞逐步转化为新的神经元,支配到并重新填充到内源性神经回路。

来自不同脑区的星形胶质细胞可以转化为不同的神经元亚型。

使用化学诱导的小鼠帕金森病模型,研究人员发现,中脑星形胶质细胞会向多巴胺能神经元转化,多巴胺能神经元为重建黑质神经回路提供轴突。

值得注意的是,纹状体的再神经化伴随着多巴胺水平的恢复和运动障碍的改善。

通过使用反义寡核苷酸暂时抑制PTB,也可以将星形胶质细胞转化为神经元,并实现疾病表型的类似逆转。

这些发现确定了一种潜在的有效且临床可行的方法,通过替换丢失的神经元来治疗神经变性。

 

原始出处:

Hao Qian et al. Reversing a model of Parkinson’s disease with in situ converted nigral neurons. Nature (2020).

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1884416, encodeId=e1c318844163a, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Oct 04 00:28:57 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813759, encodeId=04c6813e591e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 08:08:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389220, encodeId=ecd4138922098, content=<a href='/topic/show?id=acf3840e459' target=_blank style='color:#2F92EE;'>#胶质细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84074, encryptionId=acf3840e459, topicName=胶质细胞)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Sat Jun 27 11:28:57 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799850, encodeId=566ee998505c, content=自愿参加临床实验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5af5325692, createdName=金黎明, createdTime=Thu Jun 25 21:21:47 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799848, encodeId=7491e998483f, content=老一辈生物学家, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Thu Jun 25 20:54:58 CST 2020, time=2020-06-25, status=1, ipAttribution=)]
    2020-10-04 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1884416, encodeId=e1c318844163a, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Oct 04 00:28:57 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813759, encodeId=04c6813e591e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 08:08:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389220, encodeId=ecd4138922098, content=<a href='/topic/show?id=acf3840e459' target=_blank style='color:#2F92EE;'>#胶质细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84074, encryptionId=acf3840e459, topicName=胶质细胞)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Sat Jun 27 11:28:57 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799850, encodeId=566ee998505c, content=自愿参加临床实验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5af5325692, createdName=金黎明, createdTime=Thu Jun 25 21:21:47 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799848, encodeId=7491e998483f, content=老一辈生物学家, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Thu Jun 25 20:54:58 CST 2020, time=2020-06-25, status=1, ipAttribution=)]
    2020-08-27 14818eb4m67暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1884416, encodeId=e1c318844163a, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Oct 04 00:28:57 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813759, encodeId=04c6813e591e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 08:08:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389220, encodeId=ecd4138922098, content=<a href='/topic/show?id=acf3840e459' target=_blank style='color:#2F92EE;'>#胶质细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84074, encryptionId=acf3840e459, topicName=胶质细胞)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Sat Jun 27 11:28:57 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799850, encodeId=566ee998505c, content=自愿参加临床实验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5af5325692, createdName=金黎明, createdTime=Thu Jun 25 21:21:47 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799848, encodeId=7491e998483f, content=老一辈生物学家, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Thu Jun 25 20:54:58 CST 2020, time=2020-06-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1884416, encodeId=e1c318844163a, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Oct 04 00:28:57 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813759, encodeId=04c6813e591e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 08:08:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389220, encodeId=ecd4138922098, content=<a href='/topic/show?id=acf3840e459' target=_blank style='color:#2F92EE;'>#胶质细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84074, encryptionId=acf3840e459, topicName=胶质细胞)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Sat Jun 27 11:28:57 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799850, encodeId=566ee998505c, content=自愿参加临床实验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5af5325692, createdName=金黎明, createdTime=Thu Jun 25 21:21:47 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799848, encodeId=7491e998483f, content=老一辈生物学家, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Thu Jun 25 20:54:58 CST 2020, time=2020-06-25, status=1, ipAttribution=)]
    2020-06-25 金黎明

    自愿参加临床实验。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1884416, encodeId=e1c318844163a, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Oct 04 00:28:57 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813759, encodeId=04c6813e591e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 08:08:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389220, encodeId=ecd4138922098, content=<a href='/topic/show?id=acf3840e459' target=_blank style='color:#2F92EE;'>#胶质细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84074, encryptionId=acf3840e459, topicName=胶质细胞)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Sat Jun 27 11:28:57 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799850, encodeId=566ee998505c, content=自愿参加临床实验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5af5325692, createdName=金黎明, createdTime=Thu Jun 25 21:21:47 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799848, encodeId=7491e998483f, content=老一辈生物学家, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Thu Jun 25 20:54:58 CST 2020, time=2020-06-25, status=1, ipAttribution=)]
    2020-06-25 mswert122

    老一辈生物学家

    0

相关资讯

Nat Chem Biol: 哈佛大学研究发现:一组分子有望治疗帕金森病

帕金森病是一种常见的神经功能障碍疾病,主要影响中老年人,是继肿瘤、心脑血管病之后中老年的“第三杀手”。

Brain:发作性快动眼睡眠行为障碍中痴呆和帕金森症的风险及预测因素

发作性快动眼睡眠行为障碍(iRBD)是帕金森病、卢氏痴呆伴卢氏体痴呆和多系统萎缩的强大早期信号。这为直接观察前兆性神经退行性状态提供了一个前所未有的机会,并有可能进行神经保护性治疗的干预。对于未来的神

npj Parkinson's Disease:帕金森源于肠道又添新证,帕金森病患者肠道中有过量的机会性病原体

导言:在帕金森病(PD)中,胃肠道特征是很常见的,并且常常先于运动体征。早在2003年,德国科学家海科·布拉克(Heiko Braak)博士及其同事就提出,帕金森病可能开始于肠道,由病原

JAMA Neurol:昼夜节律紊乱增加老年人群帕金森风险

昼夜节律的降低与PD发病风险增加相关,提示它可能是发生PD的一个重要前驱特征

言语不清、肢体抖动 1 年,你的诊断是?

帕金森病(PD)和多系统萎缩(MSA)通常在疾病早期阶段很难鉴别,部分 MSA患者脑桥“十字征”或壳核外缘“裂隙征”不典型甚至缺如,那我们如何做到不误诊呢?

帕金森病全麻术后上呼吸道梗阻一例

患者,男,74岁,158cm,67kg,诊断:前列腺增生,拟在全身麻醉下行经尿道前列腺气囊扩张术。既往帕金森病史2年,长期规律服用多巴丝肼片、左卡双多巴等抗帕金森病药物直至术前。手术当日07:00服用